ALLIANCE FOR BIOPHARMACEUTICAL COMPETITIVENESS AND INNOVATION

Total Lobbying Spend

Filings

Firms Hired

Active Period

2016–2025

Spending by Year

Annual lobbying expenditures

Year	Total Spent	Filings	Firms
2025	—	4	1
2024	—	5	1
2023	—	4	1
2022	—	4	1
2021	—	4	1
2020	—	4	1
2019	—	4	1
2018	—	4	1
2017	—	4	1
2016	—	6	1

Most frequently reported lobbying issues

Issue Code	Description	Reports
Taxation/Internal Revenue Code	—	43

Lobbying firms retained by this client

Firm Name	Total Paid	Filings
THE WASHINGTON TAX & PUBLIC POLICY GROUP	—	43

Source: Senate Lobbying Disclosure Act (LDA) filings.